PetMed Express (PETS) Faces Investor Scrutiny Amid Filing Delays, Executive Departures, Admitted Accounting Rule Violations -- Hagens Berman
Provided By PR Newswire
Last update: Oct 10, 2025
SAN FRANCISCO, Oct. 10, 2025 /PRNewswire/ -- Investors in PetMed Express (NASDAQ: PETS) have seen the price of their shares steadily decline by about 26% since June 16, 2025, when the company announced it would not timely file its annual financial statements for its year ended March 31, 2025. Later disclosures reveal serious additional company problems.
Read more at prnewswire.com
